Bianca Rocca/LinkedIn
Jun 29, 2026, 13:18
Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn about a recent article by Valeria Caso et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
”Delighted to share this just-released opinion by leading international experts addressing the current and evolving debate on Factor XI as a pharmacological target.
I hope you enjoy the article, and I wish everyone a great week!”
Title: Current opinion: the OCEANIC trial journey: from failure to breakthrough?
Authors: Valeria Caso, Hugo ten Cate, Isabelle C van Gelder

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines